When you take Ozempic, the drug mimics a natural gut hormone to lower blood sugar, slow digestion, and reduce appetite. Most people notice decreased hunger within the first few weeks, though the full effects on blood sugar and weight build gradually over several months as the dose increases. The experience involves a weekly injection, a structured dose escalation, and for many people, a period of adjusting to gastrointestinal side effects.
How Ozempic Works in Your Body
Ozempic contains semaglutide, a synthetic version of a hormone your gut naturally releases after eating called GLP-1. This hormone does three things simultaneously: it signals your pancreas to release more insulin when blood sugar is high, it suppresses another hormone (glucagon) that raises blood sugar, and it slows the rate at which food leaves your stomach. The result is lower blood sugar after meals and a prolonged feeling of fullness.
The drug also acts on your brain. Semaglutide activates specific neurons in a region at the base of the brain called the dorsal vagal complex, which serves as a relay station between your gut and higher brain areas involved in satiety. These neurons trigger downstream pathways that reduce hunger and shift your body toward burning fat for energy. This is why many people on Ozempic describe not just eating less, but genuinely wanting less food and thinking about food less often.
The Dosing Schedule and What to Expect
Ozempic is a once-weekly injection you give yourself on the same day each week, with or without food. You start at 0.25 mg for the first four weeks, which is not actually a therapeutic dose. It exists solely to let your body adjust. After that, your dose increases to 0.5 mg, and depending on how you respond, your doctor may eventually raise it to 1 mg or the maximum of 2 mg.
This gradual ramp-up matters because jumping straight to a full dose would make side effects significantly worse. Even with the slow increase, most people experience some adjustment period at each new dose level. The full blood sugar and weight effects typically take months to materialize, so the early weeks are really about building tolerance.
Side Effects in the First Few Months
Nausea is the most common experience, especially during the first weeks and after each dose increase. In clinical trials, gastrointestinal symptoms including nausea, vomiting, diarrhea, abdominal pain, and constipation each affected at least 5% of patients. At the 2 mg dose, 34% of participants reported GI side effects, compared with about 31% at 1 mg. For most people, these symptoms are mild to moderate and fade as the body adjusts.
About 3% to 4% of people in trials found the GI side effects bad enough to stop taking the medication entirely. Severe gastrointestinal reactions were rare, occurring in under 1% of patients. Eating smaller meals, avoiding high-fat or greasy foods, and eating slowly can help manage nausea during the adjustment period. Many people find the nausea peaks in the first month or two and then largely resolves.
Blood Sugar Changes
For people with type 2 diabetes, Ozempic produces meaningful improvements in blood sugar control. In real-world data, patients on the 1 mg weekly dose saw their A1c drop by an average of 1.2 percentage points, and those who stayed on the medication consistently saw reductions of 1.4 points. Clinical trial results were even stronger, with A1c reductions of 1.5 to 1.8 percentage points over 30 to 56 weeks. To put that in perspective, an A1c drop of 1.5 points could take someone from poorly controlled diabetes (say, 8.5%) down to a well-managed range near 7%.
Weight Loss: How Much and How Fast
Weight loss on Ozempic tends to be gradual. It typically begins in the first month but accelerates as doses increase and appetite suppression takes full effect. People using higher doses of semaglutide in clinical settings commonly lose 10% to 15% of their body weight over the course of a year or longer, though individual results vary widely.
The composition of that weight loss matters. Research shows that semaglutide reduces both fat mass and lean mass (muscle). However, the ratio of lean mass to total body weight actually improves, meaning you lose proportionally more fat than muscle. Still, some larger trials have found significant lean mass reductions, which is why many doctors now recommend resistance training alongside the medication to preserve muscle.
Serious Risks to Be Aware Of
There have been reports of gastroparesis, a condition where the stomach’s ability to empty is severely impaired, in people taking semaglutide. The FDA has received reports of this complication, including cases where the condition persisted after stopping the drug. However, in a large two-year study of semaglutide in people with overweight or obesity, no cases of gastroparesis were reported, even though 82% of participants on the drug experienced some form of GI symptoms compared to 54% on placebo. The relationship between semaglutide and gastroparesis remains under investigation, and it appears to be uncommon.
Ozempic also carries a boxed warning about thyroid tumors based on animal studies. Pancreatitis has been reported in some patients as well, though this is rare. Signs to watch for include severe abdominal pain that radiates to your back and doesn’t go away.
What Happens If You Stop
One of the most important things to understand about Ozempic is that its effects are tied to continued use. A 2025 systematic review published in The BMJ found that people taking newer, more effective versions of these drugs (including semaglutide) regained an estimated 9.9 kg (about 22 pounds) within the first year of stopping treatment. The mathematical models projected a return to baseline weight roughly 1.5 years after stopping.
Interestingly, behavioral support during active treatment made a significant difference. Patients who received structured behavioral counseling alongside the medication lost about 6.7 kg (15 pounds) more during treatment. But after stopping, those same patients regained weight faster, at about 0.3 kg per month more than those without intensive support. This suggests the medication itself, not the behavioral changes, is doing much of the heavy lifting on weight maintenance.
This doesn’t mean the drug is useless if discontinued. Some people use it as a bridge to establish new eating habits, reach a healthier weight for surgery, or manage diabetes through a critical period. But for sustained weight management, most evidence points toward long-term use being necessary to maintain results.